V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280005779 | 280003625 | 1.57 | 83.6 | Adjuvant (A) | 2013-05-01 | 2013-05-22 | DARS Trial | 02 | N | 280029676 | DE-ESCALATE TRIAL |
| 280005780 | 280003626 | 1.6 | 55.1 | Palliative (P) | 2018-05-09 | 2018-05-21 | CHOP R - 21 days | 2 | N | 280029677 | CARBOPLATIN + PEMETREXED |
| 280005781 | 280007947 | 1.65 | 91 | Palliative (P) | 2016-05-30 | 2016-06-02 | GemCarbo Days 1+8 | 02 | N | 280029678 | CISPLATIN + FLUOROURACIL + RT |
| 280005782 | 280003627 | 1.79 | 52 | Adjuvant (A) | 2016-08-04 | 2016-08-23 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 280029679 | CAPECITABINE |
| 280005783 | 280007948 | null | 80.2 | Curative (C) | 2017-01-18 | 2017-02-28 | Mitomycin Intravesical | N | N | 280029680 | CISPLATIN + FLUOROURACIL + RT |
| 280005784 | 280007948 | 1.67 | 95.8 | Palliative (P) | 2014-12-01 | 2014-12-01 | CompARE Trial | N | N | 280029680 | PEMBROLIZUMAB |
| 280005785 | 280003628 | 1.56 | 60 | Neo-adjuvant (N) | 2014-01-13 | 2014-01-14 | VAC | 02 | null | 280029682 | VIDE |
| 280005786 | 280003629 | 1.65 | 82.25 | Palliative (P) | 2017-02-19 | 2017-02-19 | Gemcitabine + Capecitabine | N | N | 280029683 | TRABECTEDIN |
| 280005787 | 280007949 | 0 | 75 | Palliative (P) | 2017-06-09 | 2017-06-21 | Cyclophosphamide oral | 02 | null | 280029685 | DOCETAXEL |
| 280005788 | 280003630 | 1.84 | 70.25 | Palliative (P) | 2013-10-16 | 2013-11-14 | Cisplatin + Pemetrexed | N | N | 280029686 | DOXORUBICIN + OLARATUMAB |
| 280005789 | 280003631 | 1.74 | 66.5 | Palliative (P) | 2017-07-19 | 2017-07-29 | Trabectedin | 2 | N | 280029688 | DOXORUBICIN + OLARATUMAB |
| 280005790 | 280003632 | 1.8 | 70 | Curative (C) | 2013-06-10 | 2013-06-11 | Trabectedin | N | N | 280029689 | EURO-EWING |
| 280005791 | 280003633 | 1.74 | 74 | Palliative (P) | 2016-03-18 | 2016-03-18 | PACLITAXEL | N | null | 280029690 | VIDE |
| 280005792 | 280007950 | 1.66 | 86 | Disease modification (D) | 2016-08-30 | 2016-08-30 | GemCarbo Days 1+8 | N | N | 280029691 | SUNITINIB |
| 280005793 | 280007950 | -1 | 50.7 | null | 2018-02-25 | 2018-03-02 | ECX | null | null | 280029691 | FLUOROURACIL + MITOMYCIN + RT |
| 280005794 | 280007950 | null | 70 | Palliative (P) | 2018-01-28 | 2018-01-28 | CISPLATIN + FLUOROURACIL + RT | Y | N | 280029691 | CAPECITABINE + CISPLATIN |
| 280005795 | 280003634 | -1 | 71.7 | Palliative (P) | 2017-02-11 | 2018-03-02 | VAC | N | N | 280029698 | CAPECITABINE + CARBOPLATIN |
| 280005797 | 280003636 | null | null | Neo-adjuvant (N) | null | 2015-08-31 | CETUXIMAB + CISPLATIN + FU | N | null | 280029702 | CARBO + FLUOROURACIL |
| 280005798 | 280003636 | 1.49 | 62.4 | Palliative (P) | 2017-02-21 | 2017-02-21 | FLUOROURACIL + MITOMYCIN + RT | null | null | 280029702 | DOXORUBICIN + OLARATUMAB |
| 280005799 | 280003637 | 1.64 | 60 | Palliative (P) | 2017-10-27 | 2017-10-28 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 1 | N | 280029707 | TRABECTEDIN |
| 280005800 | 280003637 | null | 58.3 | null | 2017-09-17 | 2017-09-19 | EURO-EWING | N | null | 280029707 | VIDE |
| 280005801 | 280003638 | 1.6 | 58.6 | Curative (C) | 2013-05-20 | 2013-05-20 | CAPECITABINE + OXALIPLATIN | 02 | null | 280029710 | IMATINIB |
| 280005802 | 280007953 | 1.82 | 27.75 | Palliative (P) | 2017-05-18 | 2017-06-05 | GemCarbo Days 1+8 | null | null | 280029711 | PACLITAXEL |
| 280005803 | 280003639 | 1.79 | 17.7 | Palliative (P) | 2017-05-25 | 2017-06-09 | EW EuroEwing 99 : VActC | N | N | 280029713 | CETUXIMAB + CISPLATIN + FU |
| 280005804 | 280007954 | null | 76 | null | 2013-10-11 | 2013-10-14 | Carbo F | N | N | 280029715 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 280005805 | 280010046 | 1.78 | 60 | Curative (C) | 2014-04-10 | 2014-04-17 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 280029718 | VIDE |
| 280005806 | 280010046 | 1.8 | null | Curative (C) | 2017-10-07 | 2017-10-07 | LANREOTIDE | N | null | 280029718 | DARS TRIAL |
| 280005807 | 280010046 | null | null | null | 2014-06-14 | 2014-06-17 | FEC 100 | N | null | 280029718 | FLUOROURACIL + MITOMYCIN + RT |
| 280005808 | 280010046 | 1.61 | 95.6 | Curative (C) | 2017-10-31 | 2017-11-22 | CARBOPLATIN + GEMCITABINE | 02 | null | 280029718 | DE-ESCALATE TRIAL |
| 280005809 | 280010046 | null | null | Curative (C) | 2014-03-02 | 2014-03-06 | AC | N | null | 280029718 | DA |
| 280005810 | 280010046 | 1.54 | 45.8 | null | 2015-11-13 | 2015-12-28 | Gemcitabine weekly | N | N | 280029718 | CISPLATIN + DOXORUBICIN |
| 280005811 | 280010046 | null | 54.7 | Disease modification (D) | 2014-02-01 | 2014-02-01 | AC | 02 | N | 280029718 | TCF |
| 280005812 | 280012118 | null | 77.15 | Curative (C) | 2013-07-17 | 2013-07-25 | GemCarbo Days 1+8 | Y | N | 280029740 | EURO-EWING |
| 280005813 | 280003640 | null | 82.5 | Palliative (P) | 2015-05-08 | 2015-05-27 | LIPOSOMAL DOXORUBICIN | null | N | 280029741 | DOCETAXEL |
| 280005814 | 280003641 | 1.54 | 62.5 | Curative (C) | null | 2014-08-28 | ECX | N | N | 280029742 | VIDE |
| 280005815 | 280003642 | null | 60 | Curative (C) | 2015-04-29 | 2015-05-21 | CAPECITABINE + GEMCITABINE | 02 | Y | 280029748 | DOXORUBICIN + GEMCITABINE |
| 280005816 | 280003642 | 1.75 | 79.7 | Palliative (P) | 2014-12-27 | 2015-01-20 | Irinotecan + Modified De Gramont | N | N | 280029748 | HCX |
| 280005817 | 280003643 | 1.78 | 127.1 | Palliative (P) | 2014-10-13 | 2014-11-10 | CISPLATIN + ETOPOSIDE | 2 | N | 280029751 | TRASTUZUMAB |
| 280005818 | 280003644 | 1.63 | 107 | Curative (C) | 2014-02-11 | 2014-02-11 | Cetuximab+Cisplatin+FU (> Cycle 2) | 02 | null | 280029753 | COMPARE TRIAL |
| 280005819 | 280003644 | 1.68 | 100.4 | Palliative (P) | 2017-06-05 | 2017-06-05 | Carbo F | N | N | 280029753 | PAZOPANIB |
| 280005820 | 280003645 | 1.83 | null | Palliative (P) | 2014-01-27 | 2014-01-28 | Cisplatin + Fluorouracil + RT 5day | N | null | 280029759 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 280005821 | 280003645 | 1.58 | null | Neo-adjuvant (N) | 2016-07-04 | 2016-07-10 | Capecitabine + Oxaliplatin 14day | Y | null | 280029759 | VIDE |
| 280005822 | 280003645 | 1.63 | 62.8 | null | 2015-02-11 | 2015-02-12 | Paclitaxel 7 day | 02 | N | 280029759 | ETOPOSIDE |
| 280005823 | 280003646 | 1.68 | 97 | Disease modification (D) | 2014-04-07 | 2014-04-10 | DARS Trial | 02 | N | 280029766 | SUNITINIB |
| 280005824 | 280007958 | null | null | Neo-adjuvant (N) | 2017-01-27 | 2017-02-04 | Liposomal Doxorubicin 50mg/m2 | N | N | 280029770 | RMS 2005 TRIAL |
| 280005825 | 280003647 | 1.6 | null | null | 2014-08-08 | 2014-08-08 | Gemcitabine weekly | N | Y | 280029771 | BLEOMYCIN |
| 280005826 | 280003647 | 1.54 | null | Palliative (P) | 2015-05-28 | 2015-06-07 | Vemurafenib | N | N | 280029771 | GEMCARBO |
| 280005827 | 280003648 | null | 83.6 | Not known (9) | 2016-01-01 | 2016-01-01 | STS Rhabdomyosarcoma RMS 2005 IVA | Y | N | 280029774 | IMATINIB |
| 280005828 | 280003648 | null | null | null | null | 2014-06-23 | IVADo | N | null | 280029774 | VIDE |
| 280005829 | 280003649 | 1.56 | 54.6 | Palliative (P) | 2016-01-18 | 2016-02-02 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 280029776 | CVP R |